The expression profile and prognostic value of APE/Ref-1 and NPM1 in high-grade serous ovarian adenocarcinoma

Apmis ◽  
2017 ◽  
Vol 125 (10) ◽  
pp. 857-862 ◽  
Author(s):  
Xiaomei Fan ◽  
Lixuan Wen ◽  
Yuehong Li ◽  
Lei Lou ◽  
Weina Liu ◽  
...  
Keyword(s):  
Expression Profile ◽  
Prognostic Value ◽  
High Grade ◽  
Ovarian Adenocarcinoma ◽  
Serous Ovarian Adenocarcinoma

Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma

2010 ◽  
Vol 119 (2) ◽  
pp. 325-331 ◽  
Author(s):  
Stefanie Scheil-Bertram ◽  
Patricia Tylus-Schaaf ◽  
Andreas du Bois ◽  
Philipp Harter ◽  
Matthias Oppitz ◽  
...  
Keyword(s):  
Excision Repair ◽  
Complementation Group ◽  
High Grade ◽  
Protein Overexpression ◽  
Poor Survival ◽  
Ovarian Adenocarcinoma ◽  
Serous Ovarian Adenocarcinoma ◽  
Group 1

The role of interferon-stimulated gene 15 in advanced stage high-grade serous ovarian adenocarcinoma

2012 ◽  
Vol 125 ◽  
pp. S140
Author(s):  
C. Tsai ◽  
T. Zaid ◽  
C. Co ◽  
M. Thompson ◽  
T. Yeung ◽  
...  
Keyword(s):  
High Grade ◽  
Advanced Stage ◽  
Ovarian Adenocarcinoma ◽  
Interferon Stimulated Gene 15 ◽  
Serous Ovarian Adenocarcinoma

Increased 131I Accumulation in the Gallbladder and High-grade Serous Ovarian Adenocarcinoma

2019 ◽  
Vol 44 (1) ◽  
pp. 61-63 ◽  
Author(s):  
Xiaobo Yao ◽  
Jiaqiong Wang ◽  
Menghua Xia ◽  
Junyong Xia ◽  
Yizhuang Cheng
Keyword(s):  
High Grade ◽  
Ovarian Adenocarcinoma ◽  
Serous Ovarian Adenocarcinoma

Abstract 408: Expression of interferon-stimulated gene 15 is a novel prognostic predictor for patients with advanced stage high-grade serous ovarian adenocarcinoma

2011 ◽  
Author(s):  
Ching-Chou Tsai ◽  
Tarrik M. Zaid ◽  
Chloe N. Co ◽  
Tsz-Lun Yeung, ◽  
Melissa S. Thompson ◽  
...  
Keyword(s):  
High Grade ◽  
Advanced Stage ◽  
Ovarian Adenocarcinoma ◽  
Prognostic Predictor ◽  
Interferon Stimulated Gene 15 ◽  
Serous Ovarian Adenocarcinoma

Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas

2021 ◽  
Vol 201 ◽  
pp. 106428
Author(s):  
Tian Xie ◽  
Xiaoyu Guo ◽  
Hao Duan ◽  
Zhenqiang He ◽  
Yonggao Mou
Keyword(s):  
Prognostic Value ◽  
High Grade ◽  
Newly Diagnosed ◽  
Inflammatory Score ◽  
High Grade Gliomas

The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies

2021 ◽  
Author(s):  
Cécile Manceau ◽  
Gaëlle Fromont-Hankard ◽  
Jean-Baptiste Beauval ◽  
Marine Lesourd ◽  
Christophe Almeras ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prognostic Value ◽  
High Grade ◽  
Cancer Pattern ◽  
Targeted Biopsies

scholarly journals Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors

2021 ◽  
pp. 030098582098513
Author(s):  
Mafalda Casanova ◽  
Sandra Branco ◽  
Inês Berenguer Veiga ◽  
André Barros ◽  
Pedro Faísca
Keyword(s):  
Mast Cell ◽  
Clinical Outcome ◽  
Prognostic Value ◽  
Histological Grade ◽  
Intraobserver Variability ◽  
Low Grade ◽  
High Grade ◽  
Mast Cell Tumors ◽  
Cutaneous Mast Cell ◽  
Grade Iii

Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qualitative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study investigates the prognostic value of volume-weighted mean nuclear volume ([Formula: see text]), a stereological estimation that provides information about nuclear size and its variability. [Formula: see text] of 55 ccMCTs was estimated using the “point-sampled intercept” method and compared with histological grade and clinical outcome. The clinical history of dogs treated with surgical excision alone was available for 30 ccMCTs. Statistical differences in [Formula: see text] were found between grade II ([Formula: see text]= 115 ± 29 µm3) and grade III ccMCTs ([Formula: see text]= 197 ± 63 µm3), as well as between low-grade ([Formula: see text]= 113 ± 28 µm3) and high-grade ccMCTs ([Formula: see text]= 184 ± 63 µm3). An optimal cutoff value of [Formula: see text] ≥ 150 µm3 and [Formula: see text] ≥ 140 µm3 was determined for grade III and high-grade ccMCTs, respectively. In terms of prognosis, [Formula: see text] was not able to predict the clinical outcome in 42% of the cases; however, cases with [Formula: see text]<125 µm3 had a favorable outcome. These results indicate that, despite having limited prognostic value when used as a solitary parameter, [Formula: see text] is highly reproducible and is associated with histological grade as well as with benign behavior.

nm23 expression in malignant ascitic effusions of serous ovarian adenocarcinoma

2001 ◽  
Author(s):  
Gianni Simone ◽  
Gaetano Falco ◽  
Maria Caponio ◽  
Carlo Campobasso ◽  
Massimo De Frenza ◽  
...  
Keyword(s):  
Ovarian Adenocarcinoma ◽  
Serous Ovarian Adenocarcinoma
Sign in / Sign up

Export Citation Format

Share Document